AERD: PERSPECTIVE OF THE USE OF LICENSED MONOCLONALS FOR TREATMENT BASED ON THEIR PHENOTYPES

Currently, the gold standard for treatment of Aspirin-Exacerbated Respiratory Disease (AERD) is desensitization with ASA. Monoclonal therapy would be a promising option for these patients. The objective of the study was to evaluate the possible indications of these licensed biologicals for patients with AERD. Retrospective study of adult patients being followed up at an asthma outpatient clinic with a history of AERD. All patients had nasal...